申请人:Purdue Pharma L.P.
公开号:US20170298027A1
公开(公告)日:2017-10-19
The present disclosure provides substituted pyrimidine compounds of Formula (I), and the pharmaceutically acceptable salts, prodrugs, and solvates thereof, wherein A
1
, X, A
2
, W
1
, W
2
, W
3
, E, Z, and R
4
are defined as set forth in the specification. The present disclosure is also directed to the use of compounds of Formula (I) to treat a disorder responsive to the blockade of sodium channels. Compounds of the present disclosure are especially useful for treating pain.